Run ID: SRR8651637
Sample name:
Date: 2024-08-08T07:32:42.284190
Number of reads: 10918205
Percentage reads mapped: 99.63
Median coverage: 302.0
Strain: lineage4.4.2
Spoligotype:
Drug-resistance: Pre-XDR-TB
| Lineage | Family | RDs | Frequency |
|---|---|---|---|
| lineage4 | Euro-American | None | 1.0 |
| lineage4.4 | Euro-American | None | 1.0 |
| lineage4.4.2 | Euro-American | None | 1.0 |
| Drug | Resistance | Supporting mutations | WHO confidence | Comment |
|---|---|---|---|---|
| rifampicin | rpoB | p.Leu430Pro | Assoc w R | |
| p.Asp435Asn | Assoc w R - Interim | Expert rule: Non-silent variants in RRDR of rpoB | ||
| isoniazid | katG | p.Ser315Thr | Assoc w R | High-level resistance |
| ethambutol | embB | p.Gln497Pro | Uncertain significance | Mutation from literature |
| pyrazinamide | pncA | p.Thr47Pro | Assoc w R | |
| streptomycin | rrs | n.514A>C | Assoc w R | |
| fluoroquinolones | ||||
| moxifloxacin | gyrB | p.Ala504Val | Assoc w R - Interim | Low-level resistance (multiple, genetically linked low-level resistance mutations are additive and confer high-level resistance) |
| gyrA | p.Ala90Val | Assoc w R | Low-level resistance (multiple, genetically linked low-level resistance mutations are additive and confer high-level resistance) | |
| ofloxacin | ||||
| levofloxacin | gyrB | p.Ala504Val | Assoc w R - Interim | |
| gyrA | p.Ala90Val | Assoc w R | ||
| ciprofloxacin | ||||
| aminoglycosides | ||||
| amikacin | ||||
| capreomycin | ||||
| kanamycin | ||||
| cycloserine | ||||
| ethionamide | ||||
| clofazimine | ||||
| para-aminosalicylic_acid | ||||
| delamanid | ||||
| bedaquiline | ||||
| linezolid |
| Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence | Comment |
|---|---|---|---|---|---|---|---|
| gyrB | 6750 | p.Ala504Val | missense_variant | 0.87 | levofloxacin | Assoc w R - Interim | |
| moxifloxacin | Assoc w R - Interim | Low-level resistance (multiple, genetically linked low-level resistance mutations are additive and confer high-level resistance) | |||||
| gyrA | 7570 | p.Ala90Val | missense_variant | 0.98 | levofloxacin | Assoc w R | |
| moxifloxacin | Assoc w R | Low-level resistance (multiple, genetically linked low-level resistance mutations are additive and confer high-level resistance) | |||||
| rpoB | 761095 | p.Leu430Pro | missense_variant | 0.99 | rifampicin | Assoc w R | |
| rpoB | 761109 | p.Asp435Asn | missense_variant | 0.98 | rifampicin | Assoc w R - Interim | Expert rule: Non-silent variants in RRDR of rpoB |
| rrs | 1472359 | n.514A>C | non_coding_transcript_exon_variant | 1.0 | streptomycin | Assoc w R | |
| katG | 2155168 | p.Ser315Thr | missense_variant | 1.0 | isoniazid | Assoc w R | High-level resistance |
| pncA | 2289103 | p.Thr47Pro | missense_variant | 1.0 | pyrazinamide | Assoc w R | |
| embB | 4248003 | p.Gln497Pro | missense_variant | 0.99 | ethambutol | Uncertain significance | Mutation from literature |
| Gene | Chromosome position | Mutation | Type | Estimated fraction | Drugs | Confidence |
|---|---|---|---|---|---|---|
| gyrA | 7362 | p.Glu21Gln | missense_variant | 1.0 | levofloxacin | Not assoc w R |
| moxifloxacin | Not assoc w R | |||||
| gyrA | 7585 | p.Ser95Thr | missense_variant | 1.0 | levofloxacin | Not assoc w R |
| moxifloxacin | Not assoc w R | |||||
| gyrA | 9304 | p.Gly668Asp | missense_variant | 1.0 | levofloxacin | Not assoc w R |
| moxifloxacin | Not assoc w R | |||||
| Rv0565c | 657409 | p.Gly21Glu | missense_variant | 0.99 | ethionamide | Uncertain significance |
| mmpL5 | 775639 | p.Ile948Val | missense_variant | 1.0 | clofazimine | Not assoc w R |
| bedaquiline | Not assoc w R - Interim | |||||
| rpsL | 781395 | c.-165T>C | upstream_gene_variant | 1.0 | streptomycin | Not assoc w R |
| Rv1258c | 1407069 | c.271delC | frameshift_variant | 1.0 | streptomycin | Uncertain significance |
| isoniazid | Uncertain significance | |||||
| pyrazinamide | Uncertain significance | |||||
| rrs | 1471659 | n.-187C>T | upstream_gene_variant | 1.0 | streptomycin | |
| kanamycin | ||||||
| capreomycin | ||||||
| amikacin | ||||||
| tsnR | 1854300 | p.Leu232Pro | missense_variant | 1.0 | linezolid | Not assoc w R |
| tlyA | 1917972 | c.33A>G | synonymous_variant | 1.0 | capreomycin | Not assoc w R |
| ndh | 2102497 | c.546T>C | synonymous_variant | 1.0 | ethionamide | |
| delamanid | ||||||
| isoniazid | ||||||
| Rv1979c | 2223293 | c.-129A>G | upstream_gene_variant | 1.0 | clofazimine | Not assoc w R |
| bedaquiline | Not assoc w R - Interim | |||||
| Rv2752c | 3066099 | p.Met31Ile | missense_variant | 0.99 | ethambutol | Not assoc w R |
| moxifloxacin | Uncertain significance | |||||
| levofloxacin | Uncertain significance | |||||
| rifampicin | Not assoc w R | |||||
| isoniazid | Not assoc w R - Interim | |||||
| ald | 3086788 | c.-32T>C | upstream_gene_variant | 1.0 | cycloserine | |
| Rv3083 | 3448348 | c.-156G>A | upstream_gene_variant | 0.99 | ethionamide | |
| Rv3236c | 3613282 | c.-166G>A | upstream_gene_variant | 0.99 | pyrazinamide | |
| mtrB | 3625065 | p.Met517Leu | missense_variant | 1.0 | bedaquiline | Uncertain significance |
| rifampicin | Not assoc w R | |||||
| embC | 4238963 | c.-900C>T | upstream_gene_variant | 1.0 | ethambutol | Not assoc w R |
| embC | 4242643 | c.2781C>T | synonymous_variant | 1.0 | ethambutol | Not assoc w R |
| embA | 4246508 | c.3276G>A | synonymous_variant | 1.0 | ethambutol | Not assoc w R |
| embB | 4248441 | p.Thr643Ile | missense_variant | 1.0 | ethambutol | Uncertain significance |
| ubiA | 4268928 | c.906C>T | synonymous_variant | 0.99 | ethambutol | Not assoc w R |
| ubiA | 4269375 | c.459G>A | synonymous_variant | 0.98 | ethambutol | Not assoc w R |
| ethA | 4326323 | c.1112_1150delGCATGATGCTTTCCGGCATCCCCAACATGGCCTACACGG | disruptive_inframe_deletion | 0.71 | ethionamide | |
| whiB6 | 4338595 | c.-75delG | upstream_gene_variant | 1.0 | capreomycin | Not assoc w R |
| amikacin | Not assoc w R | |||||
| kanamycin | Not assoc w R | |||||
| whiB6 | 4338732 | c.-211C>T | upstream_gene_variant | 1.0 | capreomycin | |
| amikacin | ||||||
| kanamycin |